Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial

Although survival has improved for kidney transplant recipients over the past several decades, long-term survival in diabetic cohorts still is significantly less than that of non-diabetic cohorts. We hypothesized that among stable kidney transplant recipients, there might be differences between subg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nephrol Renovasc Dis
Main Authors: Weinrauch, Larry A, D’Elia, John A, Weir, Matthew R, Bunnapradist, Suphamai, Finn, Peter, Liu, Jiankang, Claggett, Brian, Monaco, Anthony P
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571849/
https://ncbi.nlm.nih.gov/pubmed/28860838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S139901
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados